Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children

Clinical and Experimental Nephrology

Volumn 18, Issue 4, 2014, Pages 642-648

  Nishizaki, Naoto ^a   Hirano, Daishi ^b   Nishizaki, Yuji ^c   Fujinaga, Shuichiro ^d   Nagata, Satoru ^e   Ohtomo, Yoshiyuki ^f   Kaneko, Kazunari ^g   Shimizu, Toshiaki ^c  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^g KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Intrarenal renin angiotensin system; Tissue renin angiotensin system; Urinary angiotensinogen; Very low birth weight infants

Indexed keywords

ALBUMIN; ANGIOTENSINOGEN; BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C; AGT PROTEIN, HUMAN; BIOLOGICAL MARKER;

ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; PROTEIN URINE LEVEL; VERY LOW BIRTH WEIGHT; ADOLESCENT; ADOLESCENT DEVELOPMENT; AGE; BIRTH WEIGHT; CHILD DEVELOPMENT; COMPARATIVE STUDY; GESTATIONAL AGE; KIDNEY; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; UPREGULATION; URINE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AGE FACTORS; ANGIOTENSINOGEN; BIOMARKERS; BIRTH WEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; KIDNEY; MALE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; UP-REGULATION;

EID: 84906937429     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0896-3     Document Type: Article

References (33)

1. Kusuda S, Fujimura M, Uchiyama A, Totsu S, Matsunami K, Neonatal Research Network, Japan. Trends in morbidity and mortality among very-low-birth-weight infants from to 2008 in Japan. Pediatr Res. 2003;2012(72):531-8.
2. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733-6. (Pubitemid 39249632)
3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62-7. (Pubitemid 23018337)
4. Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol. 2007;19:1-19. (Pubitemid 46062455)
5. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994;23:171-5. (Pubitemid 24075306)
6. Mañalich R, Reyes L, Herrera M, Melendi C, Fundora I. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 2000;58:770-3. (Pubitemid 30620027)
7. Hodgin JB, Rasoulpour M, Markowitz GS, D'Agati VD. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2009;4:71-6.
8. Frankfurt JA, Duncan AF, Heyne RJ, Rosenfeld CR. Renal function and systolic blood pressure in very-low-birth-weight infants 1-3 years of age. Pediatr Nephrol. 2012;27:2285-91.
9. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation. 1994;89:493-8. (Pubitemid 24026524)
10. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-87. (Pubitemid 47481436)
11. Kohan DE. Angiotensin II and endothelin in chronic glomerulonephritis. Kidney Int. 1998;4:646-7. (Pubitemid 28357429)
12. Urushihara M, Kondo S, Kagami S, Kobori H. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol. 2010;31:318-25.
13. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170-7.
14. Katsurada A, Hagiwara Y, Miyashita K, Satou R, Miyata K, Ohashi N, Navar LG, Kobori H. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol. 2007;293:F956-60. (Pubitemid 47403368)
15. Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, Bell L. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48:221-30. (Pubitemid 44069613)
16. Kwinta P, Klimek M, Drozdz D, Grudzień A, Jagła M, Zasada M, Pietrzyk JJ. Assessment of long-term renal complications in extremely lowbirth weight children.Pediatr Nephrol. 2011;26:1095-103.
17. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension. 1999;34:1265-74. (Pubitemid 30002393)
18. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003;41:42-9. (Pubitemid 36056790)
19. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I. Liver angiotensinogen is the primary source of renal angiotensin II. J AmSoc Nephrol. 2012;23:1181-9.
20. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension. 2011;57:355-62.
21. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A, Peti-Peterdi J. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol. 2012;23:1847-56.
22. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int. 2006;69:671-8. (Pubitemid 43237635)
23. Douglas-Denton RN, McNamara BJ, Hoy WE, Hughson MD, Bertram JF. Does nephron number matter in the development of kidney disease? Ethn Dis. 2006;16:S2-40-5.
24. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Dis. 2004;43:254-9. (Pubitemid 38146323)
25. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113-22. (Pubitemid 36605822)
26. Chen YW, Chenier I, Tran S, Scotcher M, Chang SY, Zhang SL. Maternal diabetes programs hypertension and kidney injury in offspring. Pediatr Nephrol. 2010;25:1319-29.
27. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369:1208-19. (Pubitemid 46527856)
28. Bader M. Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol. 2010;50:439-65.
29. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension. 2002;39:316-22. (Pubitemid 34165142)
30. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009;338:478-80.
31. Wühl E, Schaefer F. Medscape. Managing kidney disease with blood-pressure control. Nat Rev Nephrol. 2011;7:434-44.
32. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558-65. (Pubitemid 46717523)
33. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170-7.